Ocular Hypertension
📧 Sign up to get email alerts when something new happens for Ocular Hypertension.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2009-08-06Clinical Trial Update: IntraVitreal Triamcinolone Acetonide: Preventing Raised Eye-pressure by Tracking Elevations After Topical Steroids [Phase 4]
Phase 4 clinical trial update involving intravitreal triamcinolone acetonide. It investigates monitoring intraocular pressure elevations aft…
-
CLINICAL_TRIALS trial_result · 2009-08-03Clinical Trial Update: Efficacy and Tolerability of Xalatan in Patients
A completed clinical trial investigating efficacy and tolerability of Xalatan for glaucoma and ocular hypertension, with results posted in 2…
-
CLINICAL_TRIALS trial_result · 2009-07-16Clinical Trial Update: Non Interventional Study in Patients With Open Angle Glaucoma and/or Ocular Hypertension Treated With XALATAN®
Non-interventional study in open-angle glaucoma and/or ocular hypertension treated with XALATAN (latanoprost) completed; results posted in 2…
-
FDA approval · 2009-07-14FDA Approved: DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE — Original Application (Bausch & Lomb Incorporated)
FDA approved the generic combination dorzolamide hydrochloride and timolol maleate for reduction of intraocular pressure in patients with op…
-
FDA approval · 2009-06-25FDA Approved: DORZOLAMIDE HCL — Original Application (Bausch & Lomb Incorporated)
FDA approved the original ANDA for dorzolamide hydrochloride ophthalmic solution (Dorzolamide HCl) from Bausch & Lomb Incorporated, enabling…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2009-06-11Clinical Trial Update: An Open-Label Study of an Ophthalmic Solution to Reduce Intraocular Pressure in Patients With Ocular Hypertension [NA]
An open-label study evaluating an ophthalmic solution to lower intraocular pressure in patients with ocular hypertension has completed.
-
CLINICAL_TRIALS trial_result · 2009-06-03Clinical Trial Update: Safety, Efficacy, and Pharmacokinetic Profile of DNB-001 in Subjects With Elevated Intraocular Pressure [Phase 1, Phase 2]
Phase 1/2 trial update evaluating the safety, efficacy, and pharmacokinetics of DNB-001 in subjects with elevated intraocular pressure, incl…
-
CLINICAL_TRIALS trial_result · 2009-05-29Clinical Trial Update: MK0507A Clinical Study in Patients With Glaucoma and Ocular Hypertension (0507A-149)(COMPLETED) [Phase 3]
Phase 3 study MK0507A in glaucoma (and ocular hypertension) completed with results posted.
-
CLINICAL_TRIALS trial_result · 2009-05-27Clinical Trial Update: A Study Comparing Xalacom And Xalatan In Patients With Primary Open Angle Glaucoma (POAG) Or Ocular Hypertension (OH). [Phase 3]
Phase 3 trial comparing Xalacom and Xalatan in primary open-angle glaucoma or ocular hypertension completed with results posted in 2009.
-
FDA approval · 2009-04-13FDA Approved: DORZOLAMIDE HYDROCHLORIDE — Original Application (Sandoz Inc)
FDA approved Sandoz Inc's generic dorzolamide hydrochloride ophthalmic solution under an Original Application (ANDA). It is indicated for lo…
-
CLINICAL_TRIALS trial_result · 2009-03-16Clinical Trial Update: Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-Angle Glaucoma or Ocular Hypertension [Phase 2]
DE-104 ophthalmic solution completed a Phase 2 safety and efficacy study in open-angle glaucoma and ocular hypertension.
-
CLINICAL_TRIALS trial_result · 2009-03-16Clinical Trial Update: To Investigate the Safety and Efficacy of DE-104 Ophthalmic Solution to Treat Open-Angle Glaucoma or Ocular Hypertension [Phase 2]
A Phase 2 clinical trial evaluating DE-104 ophthalmic solution for open-angle glaucoma or ocular hypertension has completed. The study was s…
-
CLINICAL_TRIALS trial_result · 2009-01-14Clinical Trial Update: Comparison of the Fixed Combinations of Brimonidine/Timolol and Dorzolamide/Timolol in Subjects With Open-Angle Glaucoma or Ocular Hypertension [Phase 4]
Phase 4 trial comparing fixed-dose combinations brimonidine/timolol and dorzolamide/timolol in open-angle glaucoma or ocular hypertension ha…
-
CLINICAL_TRIALS trial_result · 2009-01-14Clinical Trial Update: Comparison of the Fixed Combinations of Brimonidine/Timolol and Dorzolamide/Timolol in Subjects With Open-Angle Glaucoma or Ocular Hypertension [Phase 4]
A Phase 4 trial comparing fixed combinations brimonidine/timolol and dorzolamide/timolol in patients with open-angle glaucoma or ocular hype…
-
CLINICAL_TRIALS trial_result · 2009-01-12Clinical Trial Update: Ocular Signs and Symptoms in Glaucoma Patients Switched From Latanoprost 0.005% to Preservative Free Tafluprost Eye Drops [Phase 3]
Phase 3 trial update assessing ocular signs and symptoms when glaucoma patients switch from latanoprost to preservative-free tafluprost eye …
-
CLINICAL_TRIALS trial_result · 2009-01-07Clinical Trial Update: Phase 1-2 Evaluation of OT-730 Eye Drops in Reducing the Intraocular Pressure in Patients With Ocular Hypertension or Open-Angle Glaucoma [Phase 1, Phase 2]
Phase 1-2 clinical trials evaluated OT-730 Eye Drops for reducing intraocular pressure in adults with ocular hypertension or open-angle glau…
-
CLINICAL_TRIALS research · 2008-12-08Clinical Trial Update: The International Collaborative Exfoliation Syndrome Treatment Study [NA]
An update on the International Collaborative Exfoliation Syndrome Treatment Study (NCT00804115) sponsored by The New York Eye & Ear Infirmar…
-
CLINICAL_TRIALS trial_result · 2008-12-05Clinical Trial Update: Dry Eye and Irritation Comparison of Latanoprost With the Preservative Versus Travoprost Without Preservative
A completed clinical trial comparing dry eye and irritation outcomes when latanoprost with preservative is used versus preservative-free tra…
-
CLINICAL_TRIALS trial_result · 2008-12-04Clinical Trial Update: Comparison of Istalol™ 0.5% QD (Timolol Maleate/Sorbitol Complex, ISTA Pharmaceutical) to Brimonidine Tartrate 0.1% BID as Adjunctive Therapy to Latanoprost 0.005% in Adults With Ocular Hypertension (OHT) or Open-Angle Glaucoma (OAG) [Phase 4]
Phase 4 trial comparing Istalol 0.5% once daily with Brimonidine tartrate 0.1% twice daily as add-on therapy to latanoprost in adults with o…
-
CLINICAL_TRIALS trial_result · 2008-11-19Clinical Trial Update: Cosopt Versus Xalacom [Phase 4]
A Phase 4 trial comparing Cosopt with Xalacom in open-angle glaucoma and ocular hypertension has completed.
-
CLINICAL_TRIALS trial_result · 2008-11-19Clinical Trial Update: Assessing Cosopt Switch Patients [Phase 4]
Phase 4 clinical trial completed evaluating outcomes for patients switched to Cosopt (dorzolamide-timolol) in ocular hypertension and severa…
-
CLINICAL_TRIALS trial_result · 2008-11-05Clinical Trial Update: A 5-Year Postmarketing Safety Study Of Xalcom In Patients With Open Angle Glaucoma Or Ocular Hypertension [Phase 3]
This document reports the completion of a 5-year postmarketing safety study of Xalcom in patients with open-angle glaucoma or ocular hyperte…
-
CLINICAL_TRIALS trial_result · 2008-10-28Clinical Trial Update: Intraocular Pressure With Loteprednol and Dexamethasone [Phase 4]
Phase 4 clinical trial evaluating intraocular pressure effects of loteprednol and dexamethasone in open-angle glaucoma and ocular hypertensi…
-
FDA approval · 2008-10-28FDA Approved: DORZOLAMIDE HYDROCHLORIDE — Original Application (Advagen Pharma Ltd.)
FDA approves Advagen Pharma Ltd.'s dorzolamide hydrochloride as a generic eye drop for lowering intraocular pressure in glaucoma and ocular …
-
FDA approval · 2008-10-22FDA Approved: COSOPT — Supplemental Application (Thea Pharma Inc.)
The FDA approved a supplemental application for COSOPT (dorzolamide hydrochloride and timolol maleate) submitted by Thea Pharma Inc.